NYSE American - Delayed Quote USD

Retractable Technologies, Inc. (RVP)

Compare
0.7791 -0.1198 (-13.33%)
At close: September 20 at 4:00 PM EDT
0.7900 +0.01 (+1.40%)
After hours: September 20 at 7:53 PM EDT
Loading Chart for RVP
DELL
  • Previous Close 0.8989
  • Open 0.9000
  • Bid 0.7912 x 1000
  • Ask 0.8400 x 1100
  • Day's Range 0.7101 - 0.9000
  • 52 Week Range 0.7100 - 1.3400
  • Volume 862,141
  • Avg. Volume 84,593
  • Market Cap (intraday) 23.324M
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6000
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

www.retractable.com

148

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RVP

View More

Performance Overview: RVP

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RVP
29.81%
S&P 500
19.55%

1-Year Return

RVP
34.53%
S&P 500
28.32%

3-Year Return

RVP
93.38%
S&P 500
28.64%

5-Year Return

RVP
16.23%
S&P 500
89.66%

Compare To: RVP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RVP

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    23.32M

  • Enterprise Value

    -16.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    0.27

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -46.71%

  • Return on Assets (ttm)

    -4.48%

  • Return on Equity (ttm)

    -18.91%

  • Revenue (ttm)

    38.25M

  • Net Income Avi to Common (ttm)

    -18.1M

  • Diluted EPS (ttm)

    -0.6000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.9M

  • Total Debt/Equity (mrq)

    1.62%

  • Levered Free Cash Flow (ttm)

    7.4M

Research Analysis: RVP

View More

Company Insights: RVP

Research Reports: RVP

View More

People Also Watch